158 related articles for article (PubMed ID: 23778007)
1. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
[TBL] [Abstract][Full Text] [Related]
2. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.
Zhang BL; Ye Z; Xu RL; You XH; Qin YW; Wu H; Cao J; Zhang JL; Zheng X; Zhao XX
Clin Genet; 2014 Sep; 86(3):287-91. PubMed ID: 23992123
[TBL] [Abstract][Full Text] [Related]
4. A novel, de novo mutation in the
Xu Y; Gray A; Hardie DG; Uzun A; Shaw S; Padbury J; Phornphutkul C; Tseng YT
Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H283-H292. PubMed ID: 28550180
[No Abstract] [Full Text] [Related]
5. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
Miyamoto L
J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Daniel T; Carling D
J Biol Chem; 2002 Dec; 277(52):51017-24. PubMed ID: 12397075
[TBL] [Abstract][Full Text] [Related]
8. Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.
Folmes KD; Chan AY; Koonen DP; Pulinilkunnil TC; Baczkó I; Hunter BE; Thorn S; Allard MF; Roberts R; Gollob MH; Light PE; Dyck JR
Circ Cardiovasc Genet; 2009 Oct; 2(5):457-66. PubMed ID: 20031621
[TBL] [Abstract][Full Text] [Related]
9. Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.
Kim M; Hunter RW; Garcia-Menendez L; Gong G; Yang YY; Kolwicz SC; Xu J; Sakamoto K; Wang W; Tian R
Circ Res; 2014 Mar; 114(6):966-75. PubMed ID: 24503893
[TBL] [Abstract][Full Text] [Related]
10. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
11. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
Zhan Y; Sun X; Li B; Cai H; Xu C; Liang Q; Lu C; Qian R; Chen S; Yin L; Sheng W; Huang G; Sun A; Ge J; Sun N
J Mol Cell Cardiol; 2018 Apr; 117():49-61. PubMed ID: 29452156
[TBL] [Abstract][Full Text] [Related]
14. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome.
Xie C; Zhang YP; Song L; Luo J; Qi W; Hu J; Lu D; Yang Z; Zhang J; Xiao J; Zhou B; Du JL; Jing N; Liu Y; Wang Y; Li BL; Song BL; Yan Y
Cell Res; 2016 Oct; 26(10):1099-1111. PubMed ID: 27573176
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure.
Liu Y; Bai R; Wang L; Zhang C; Zhao R; Wan D; Chen X; Caceres G; Barr D; Barajas-Martinez H; Antzelevitch C; Hu D
PLoS One; 2013; 8(5):e64603. PubMed ID: 23741347
[TBL] [Abstract][Full Text] [Related]
16. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
Arad M; Benson DW; Perez-Atayde AR; McKenna WJ; Sparks EA; Kanter RJ; McGarry K; Seidman JG; Seidman CE
J Clin Invest; 2002 Feb; 109(3):357-62. PubMed ID: 11827995
[TBL] [Abstract][Full Text] [Related]
17. Atrial Lesions in a Pedigree With
Chen S; Lin Y; Zhu Y; Geng L; Cui C; Li Z; Liu H; Chen H; Ju W; Chen M
Front Cardiovasc Med; 2022; 9():840337. PubMed ID: 35360035
[TBL] [Abstract][Full Text] [Related]
18. Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
Bayrak F; Komurcu-Bayrak E; Mutlu B; Kahveci G; Basaran Y; Erginel-Unaltuna N
Eur J Heart Fail; 2006 Nov; 8(7):712-5. PubMed ID: 16716659
[TBL] [Abstract][Full Text] [Related]
19. Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy.
Ahmad F; Arad M; Musi N; He H; Wolf C; Branco D; Perez-Atayde AR; Stapleton D; Bali D; Xing Y; Tian R; Goodyear LJ; Berul CI; Ingwall JS; Seidman CE; Seidman JG
Circulation; 2005 Nov; 112(20):3140-8. PubMed ID: 16275868
[TBL] [Abstract][Full Text] [Related]
20. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.
Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H; Gorham J; Burke MA; Zhang K; Musunuru K; Gerszten RE; Wu SM; Chen CS; Seidman JG; Seidman CE
Cell Rep; 2016 Dec; 17(12):3292-3304. PubMed ID: 28009297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
